MANAMATCH Trademark

Trademark Overview


On Monday, February 22, 2021, a trademark application was filed for MANAMATCH with the United States Patent and Trademark Office. The USPTO has given the MANAMATCH trademark a serial number of 90539253. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 24, 2022. This trademark is owned by Mana Therapeutics, Inc.. The MANAMATCH trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for treating cancer that assist in evaluating and matching common Human Leukocyte Antigen (HLA) with antigen reactivity to potential cancer patients by using predetermined parameters to optimize efficacy and safety

Development of methodologies in the field of medicine to optimize a match between cell product and patient, matching common Human Leukocyte Antigen (HLA) with antigen reactivity to potential cancer patients in order to enhance the efficacy of Human Leukocyte Antigen (HLA) and specific antigen
manamatch

General Information


Serial Number90539253
Word MarkMANAMATCH
Filing DateMonday, February 22, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 24, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for treating cancer that assist in evaluating and matching common Human Leukocyte Antigen (HLA) with antigen reactivity to potential cancer patients by using predetermined parameters to optimize efficacy and safety
Pseudo MarkMANA MATCH
Goods and ServicesDevelopment of methodologies in the field of medicine to optimize a match between cell product and patient, matching common Human Leukocyte Antigen (HLA) with antigen reactivity to potential cancer patients in order to enhance the efficacy of Human Leukocyte Antigen (HLA) and specific antigen

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, May 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, May 22, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMana Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816

Party NameMana Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816

Trademark Events


Event DateEvent Description
Monday, October 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 28, 2021NON-FINAL ACTION E-MAILED
Thursday, October 28, 2021NON-FINAL ACTION WRITTEN
Wednesday, September 15, 2021ASSIGNED TO EXAMINER
Saturday, May 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 25, 2021NEW APPLICATION ENTERED IN TRAM